BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30120543)

  • 41. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.
    Canter RJ; Patel SA; Kennedy T; D'Angelica MI; Jarnagin WR; Fong Y; Blumgart LH; Freeman RB; DeMatteo RP; Abt PL
    Am J Clin Oncol; 2011 Oct; 34(5):466-71. PubMed ID: 20938319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study.
    Kim JH; Sinn DH; Gwak GY; Choi GS; Kim JM; Kwon CHD; Joh JW; Kim KY; Kim K; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Medicine (Baltimore); 2016 Aug; 95(35):e4735. PubMed ID: 27583916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.
    Teng F; Han QC; Ding GS; Ni ZJ; Fu H; Guo WY; Shi XM; Gao XG; Ma J; Fu ZR
    Sci Rep; 2015 Jun; 5():11733. PubMed ID: 26096817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
    Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
    World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
    Na GH; Kim EY; Hong TH; You YK; Kim DG
    HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
    de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
    Abdelfattah MR; Elsiesy H; Al-Manea H; Broering DC
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):398-403. PubMed ID: 29280920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
    Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Ecker BL; Hoteit MA; Forde KA; Hsu CC; Reddy KR; Furth EE; Siegelman ES; Habibollahi P; Ben-Josef E; Porrett PM; Abt PL; Shaked A; Olthoff KM; Levine MH
    Transplantation; 2018 Apr; 102(4):648-655. PubMed ID: 29319629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):406-9. PubMed ID: 24670459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation versus hepatectomy for HCC beyond the Milan criteria: A propensity score analysis.
    Shen JY; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ; Wen J
    Int J Surg; 2017 Aug; 44():33-42. PubMed ID: 28529191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
    Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
    J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size?
    Fernández JA; Robles R; Marin C; Sánchez-Bueno F; Ramirez P; Pons JA; Garre MC; Pérez D; Parrilla A; Navalón JC; Parrilla P
    Transplant Proc; 2003 Aug; 35(5):1818-20. PubMed ID: 12962807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.